Screening and validation of novel serum panel of microRNA in stratification of prostate cancer

BACKGROUND: Owing to the heterogeneous nature of prostate cancer (PCa) and errors in the characterization of the disease, researchers have been trying to unveil molecular biomarkers like microRNA (miRNA) as diagnostic markers. The purpose of our study is to demonstrate the precision of a panel of mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Manoj, Anveshika, Ahmad, Mohammad K., Prasad, Gautam, Kumar, Durgesh, Mahdi, Abbas A., Kumar, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513910/
https://www.ncbi.nlm.nih.gov/pubmed/37745909
http://dx.doi.org/10.1016/j.prnil.2023.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513910/
https://www.ncbi.nlm.nih.gov/pubmed/37745909
http://dx.doi.org/10.1016/j.prnil.2023.06.002

Ejemplares similares